Several studies have shown an increased risk for infection and cancer in alcoholic patients. The mechanisms for such observations remain largely unknown. In an effort to investigate the possibility of immunological dysfunction In alcoholism, we studied three immune parameters in 47 hospitalized chronic alcoholic patients and 47 ageand sex-matched normal controls. The immune measures were: (1) lymphocyte phenotyping, with estimates of percentages of T cells, B cells, T helpers, T suppressors, natural killer (NK) cells, and cells carrying the activation markers IL2R1 and 12; (2) NK cell activity; and (3) lymphokine-activated killer cell activity. Results indicate a significant increase in the IL2R and l2 lymphocyte markers in alcoholic patients compared with matched controls. We also found a nonsignificant trend for a decrease in the percentage of suppressor T cells in the alcoholic group, as well as a trend for a negative correlation between the percentage of T suppressor cells and age. There were no significant differences in either NK or lymphokine-activated killer cell activities between the two groups. Furthermore, there were no significant associations between duration and intensity of alcohol consumption and any of the immune measures. These results suggest subtle alterations in immune regulation in alcoholic patients that cannot be explained solely on the basis of duration and/or amount of alcohol consumed.
tion increased. Other investigators have shown either an increa~e,~ no change," or a decrease"," in NK activity in alcohol-consuming animals compared with controls. Human studies are relatively few, and possible confounding variables are many. Charpentier et a1.I3 found an impairment in lymphocyte NK cell activity in chronic alcoholics, but only in those with active liver cirrhosis, and particularly those with severe malnutrition. Irwin et al. I4 confirmed the reduction in NK activity in alcoholics, even in those without evidence of liver cirrhosis or malnutrition, but found no clear relation with the amount of alcohol consumed. Saxena et al.,I5 on the other hand, reported increased NK activity in lymphocytes from alcoholic subjects in spite of nutritional deficiencies and other drug addictions. Other studies have shown that immune parameters, including NK activity, were not significantly different in alcoholic patients and normal controls. I6 In this study, we report our immunological findings on hospitalized chronic alcoholic patients and age-and sexmatched normal controls. Patients and control were given several immunological tests, including lymphocyte phenotyping with monoclonal antibodies and functional assays of both NK and lymphokine-activated killer (LAK) cell activities. Both patients and controls were also given extensive clinical and demographic assessments, with emphasis on duration and quantity of alcohol use.
METHODS
Subjects for the study were 47 alcoholic patients and 47 age-and sexmatched normal controls. All alcoholic patients were screened by the University of Michigan Alcohol Research Center and were hospitalized at one of the University of Michigan alcohol treatment facilities. Screening by the Alcohol Research Center was done by trained personnel and consisted of an extensive evaluation of clinical and demographic features, with special emphasis on drinking behavior. Each patient was age-and sex-matched with a normal control. Both patients and controls were evaluated with a structured psychiatric interview, the Diagnostic Interview Schedule," from which a DSM-III-R'8 diagnosis was made. All patients met DSM-111-R criteria for alcohol abuse and/or dependence as reflected in the Diagnostic Interview Schedule interview. No other psychiatric diagnosis was made. None of the normal controls met criteria either past or present for any psychiatric diagnosis. Both patients and controls were relatively healthy and free of severe medical illness known to interfere with immune regulation. Illnesses that were considered exclusionary criteria included cancer, systemic infection, stroke, insulindependent diabetes mellitus, liver cirrhosis, and the like. Thirteen patients were drug-free. The remainder were taking one or more pharmacological agents, including psychotropic medications. Immune-related medications, such as antiinfectious and antiinflammatory medications, were not allowed. Drinking severity was assessed with estimates of lifetime average drinks per day and years of heavy drinking. Mood states were rated with the Hamilton Rating Scale for Depression (HRSD)I9 and the Profile of Mood States (POMS)." In addition, severity of life events was assessed with the Holmes and Rahe life events schedule2' and a line scale for the perception of stress.Zz
Lymphocyte Separation
Blood samples from both patients and age-and sex-matched normal controls were drawn between 8:OO and 9:00 in the morning in heparinized tubes. Lymphocytes were separated by a mo&fied method of B o y~m .~~ Blood was diluted with an equal volume of phosphate-buffered saline (PBS) and centrifuged at 400 X g for 30 min at room temperature over a cushion of Ficoll-Hypaque solution. The mononuclear cells were then harvested, washed three times with PBS, and resuspended in RPMI 1640 medium containing 25 mM HEPES buffer supplemented with 10% heatinactivated fetal calf serum (Gibco, Grand Island, NY), 80 pglml gentamicin (Schering Corp., Kenilworth, NJ), and 300 gg fresh glutamine/ml (complete medium). Mononuclear cells were depleted of adherent monocytes by passage over a column of Sephadex G-10 beads (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated in the same complete medium. The cell recovery was >70% of the total input, and monocyte contamination as indicated by nonspecific esterase staining was <2%.
Lymphocyte Phenotyping
For the lymphocyte phenotyping, lo6 lymphocytes from each subject and matched control were washed and incubated separately with the following commercially available monoclonal antibodies (Coulter Immunology, Hialeah, FL): CD2 (total T cells), CD4 (helper/inducer T cells), CDs (suppressor/cytotoxic T cells), CDZo (total B cells), CD56 (NK cells), and the activation markers ILzRl (defining the receptor for interleukin-2) and Iz (an HLA-D/DR related Ia-like antigen). In addition to these monoclonal antibodies, a negative control of mouse IgG was used to provide a baseline for flow cytometry. The cells were incubated with 10 pl of the respective monoclonal antibodies at 4°C for 30 min. Following incubation the cells were washed three times with MEM medium containing 2% fetal calf serum and then fixed with 1 % formalin in PBS. The labeled and fixed cells were later analyzed by flow cytometry with the fluorescein-activated cell sorter (EPICS), a core facility at the University of Michigan Medical Center.
Assay of NK Activity
NK activity was determined in a direct V r release assay as previously de~cribed.2~ Briefly, a fixed number of viable effector cells were prepared in varying dilutions to give 5 0 1,25: 1,12.5: 1,6.25:1, and 3.125: 1 effector to target (ET) cell ratios. Effector cells were added to triplicate cultures of slCr-labeled target cells (K562 cell line) in a final volume of 0.2 ml in V bottom microtiter plates (Dynatech Labs, Alexandria, VA). After centrifugation at 40 X g for 5 min, they were incubated at 37'C in a humidified atmosphere of 5% C02 in air for 4 hr. At the end of incubation, plates were spun at 400 x g for 5 min, and 100 fil aliquots of supernatants were removed from each well and transferred to glass tubes to be read in a Packard model 593 gamma counter. Assay of LAK Cell Activity LAK cell activity assays were performed as described.% Briefly, a fixed number of cells from the lymphocyte preparation was incubated for 5 days in a complete medium to which 10 units/ml of human recombinant interleukin-2 (Collaborative Biomedical Products, Inc., Lexington, MA) was added to generate LAK cells. LAK cell cytotoxicity was then assessed using a standard 4-hr "Cr release assay against SB, an NK-resistant human leukemia B cell line. A control culture that was not treated with IL-2 produced 4% of total 5'CR release.26 Results are expressed as percentage of cytotoxicity, as with the NK assays.
Statistical Analvsis
The primary data analysis compared patients and their matched control subjects on demographic, clinical, and immunological measures (lymphocyte phenotyping, NK and LAK cell activities)
Numbers of patient-control pairs varied for lymphocyte phenotyping and other laboratory tests. Although 47 pairs were studied, accurate LU measures for the NK assay were available for 42 pairs. LAK cell assays were available for 11 pairs. Most lymphocyte subsets were available for 36 pairs, but I2 and IL2RI were added later and are presented here for 15 pairs only.
RESULTS
Demographic and clinical features for both the alcoholic patients and the normal controls are presented in Table  1 . There were no significant differences in either age or sex distribution, because patients were age-and sexmatched with normal controls. As expected, the alcoholic patients had a significantly higher average number of drinks per day (t = 7.653; p < 0.0001); they also had a significantly longer duration of heavy drinking ( t = 6.997; p < 0.0001). There were, however, no significant differences in days since last drink between alcoholic patients and their matched controls ( t = -1.663; p > 1.0). Furthermore, alcoholic patients scored significantly higher on the HRSD ( t = 4.525; p < 0.0001) and the POMS depression subscale (t = 4.980; p < 0.0001). They also reported Results of the lymphocyte phenotyping are presented in Table 2 . There were no significant differences in the percentage of T cells, B cells, or NK cells between the two groups. There was a suggestion that alcoholic patients may have a lower percentage of suppressor cells CD8 ( t = 1.923; p = 0.063), and a trend toward higher helper-suppressor T cell ratios CD4/CD8 ( t = 1.989; p = 0.0545). Further, we found significantly higher percentages of lymphocytes carrying the activation markers ILzRl ( t = -2.599; p = 0.022) and significantly higher percentages of lymphocytes carrying the activation marker Iz ( t = -3.422; p = 0.005) in alcoholic patients compared with their matched controls. Figure 1 shows the results of the fimctional assays comparing NK activity between the alcoholic patients and their matched controls. Differences in percentage cytotoxicity between the two groups were not statistically significant for any of the E:T ratios used. The corresponding t Comparisons of LAK cell activities between alcoholic patients and matched controls are shown in Fig. 2 . Here again, there were no significant differences between the two groups for any of the E:T ratios examined. Corresponding t and p values for the 4 E:T ratios were t = = 0.323; and t = -1.455, p = 0.206, respectively.
Because age has often been found to correlate negatively with different immune variables, we examined the potential effects of age on the distribution of the different lymphocyte subsets, as well as the effects of age on both NK and LAK cell activities. There were no significant associations between patient age and any of the immune variables studied. We did, nevertheless, find a nonsignificant negative association between age and CD8 (Y = -0.289;~ = 0.087) in the alcoholic patients but not among the control subjects. There were also no significant differences in immune measures between medicated and unmedicated patients. Furthermore, there were no significant associations between CDs, IL2RI or I2 and any of the pared with age-and sex-matched normal controls. The immunological assessment included lymphocyte phenotyping with monoclonal antibodies representing the major lymphocyte subsets (T cells, B cells, NK cells, T helpers, and T suppressors), as well as the activation markers ILzR, and Iz. In addition to the lymphocyte phenotyping, the immunological assessment included two functional assays: NK and LAK cell activities. Each patient was age-and sex-matched with a normal control, and all immune assays were performed simultaneously on fresh blood samples from patients and their respective controls to minimize the potential effects of interassay variation. In addition, we collected extensive demographic and clinical data, including potential confounding variables, such as depression and stress on both patients and controls.
Results of the specific lymphocyte subsets show no significant differences between alcoholic patients and matched normal controls. Similarly, there were no significant differences between these two groups in either NK or LAK cell activities. These data are consistent with previously published reports.I6 Our data also reveal no significant associations between patient age and any of the immune variables under investigation. There was, however, a nonsignificant trend for a negative association between age and the percentage of T suppressor cells in alcoholic patients but not in controls. Again, these findings are consistent with published reports suggesting a decline in several immune parameters with age, but not necessarily in CD4/CDg ratios2' or NK activity. 28 Our results also indicate a significant increase in the activation markers IL2RI and Iz among alcoholic patients compared with matched normal controls. This activation seems to be independent of the duration of drinking, amount of alcohol consumed, or time elapsed since last drink. Alcoholic patients were also significantly more depressed, and experienced significantly more stressful life events, but there were no significant associations between either IL2RI or I2 and HRSD scores, POMS depression scores, or Life Events scores (data not shown). Alcoholic patients may also suffer from a variety of medical problems, including nutritional deficiencies and liver disease. In this study, however, patients with malnutrition or severe liver disease, including liver cirrhosis, were excluded. Patients with other serious medical illness were also excluded. It is therefore possible that the use of alcohol may activate certain types of lymphocytes resulting in a larger number of lymphocytes in alcoholic patients expressing the activation markers IL2RI or 12. It is also possible that a defect may arise in the binding of the monoclonal antibodies to the ILzRl and 12 in the alcoholic patients resulting in nonspecific and therefore increased binding to these antibodies. Still another possibility is that the alcoholic patients may express increased activation antigens in response to nonspecific insults to the immune system possibly related to subclinical inflammation or infection associated with alcoholism. Further research needs to be conducted to consider these possibilities.
In summary, we have compared lymphocyte phenotyping, NK and LAK cell activities in a group of hospitalized chronic alcoholic patients and individually matched ageand sex-matched normal controls. Alcoholic patients had a significant increase in the percentage of the activation markers IL2R1 and 12. There were, however, no significant differences in either NK or LAK cell activities between the two groups. These studies suggest subtle alterations in immune regulation in alcoholic patients compared with matched controls. The clinical significance of these observations remains to be determined.
